Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= PCSK9 inhibitor
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(3)
+
-
Availability
Open access
(4)
+
-
Creation Date
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(2)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(2)
+
-
Scholarly Publications
(2)
+
-
Topic
PCSK9 inhibitor
(4)
+
-
Acute coronary syndrome
(2)
+
-
Author
Goodman, S.G.
(3)
+
-
Jukema, J.W.
(3)
+
-
Manvelian, G.
(3)
+
-
Pordy, R.
(3)
+
-
Scemama, M.
(3)
+
-
Schwartz, G.G.
(3)
+
-
Steg, P.G.
(3)
+
-
Szarek, M.
(3)
+
-
Bittner, V.A.
(2)
+
-
Diaz, R.
(2)
+
-
ODYSSEY OUTCOMES Investigators
(2)
+
-
White, H.D.
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
Effect of alirocumab on cataracts in patients with acute coronary syndromes
Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction
Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol
Future drugs in atherosclerotic cardiovascular disease